Nicox secures PDUFA date for glaucoma treatment in April 2027

Nicox announces April 2027 as the PDUFA date for NCX 470, its glaucoma treatment.

Published 3j1 sourceNotableupdated 3j

≈ 17sSpeed

The fact

This milestone represents a major regulatory advance for the company.

The FDA's decision could pave the way for commercialization.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 27, 2026